Oligo Probe Manufacturing Will Incur Brunt of Layoffs at Third Wave | GenomeWeb

NEW YORK, April 29 - Third Wave Technologies' manufacturing divisions will be hardest hit as the company starts cutting 25 percent of its workforce in a broader effort to cut costs.

Third Wave, which announced the staff reductions last week, had a headcount of roughly 300 people at the end of 2001. A spokesman said that while the lay offs were "across the board," they do not forecast a departure from genomics research and that all of its product development activities will continue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.